Vesicare

In an effort to optimize treatment for individuals who suffer from urinary incontinence, the pharmaceutical industry has developed and manufactured a medication for overactive bladder symptoms called Vesicare. Medication options have included alpha blockers and anti-spasmodic to help control the over active bladder spasms that occur in some individuals.

Overactive bladder does not always lead to urinary incontinence. It does lead to significant urges to urinate which can lead to urinary incontinence when not addressed immediately. In the past, this condition was associated with aging and considered an unfortunate symptom of growing older. Today, physicians recognize overactive bladder as a real medical condition and not a normal sign of aging.

Overactive bladder has kept many individuals from enjoying a night out with their friends without constantly searching for the nearest bathroom or wearing a hat in case they leak.

An overactive bladder will be diagnosed by your primary care physician using a thorough medical history and physical examination as well as description of symptoms. In some cases the physician will also request a voiding cystourethrogram, which is an x-ray procedure used to take pictures while an individual is urinating to help the physician better understand the individual structural changes and physiological differences that each person experiences.

Vesicare is one medication that can be prescribed when an individual suffers from overactive bladder. Prior to taking it be sure to tell your physician if you have glaucoma, liver disease, kidney disease or a blockage of in your stomach or intestines. Vesicare can also affect the electrical system in the heart and individuals have a history of a long QT syndrome should not take the medication.

When taking Vesicare individuals can become overheated or dehydrated because it will decrease the amount of perspiration which leads to an increased risk of heat stroke. Other side effects can impair vision or reaction time. Individuals who are driving should be sure they are alert an able to see clearly he for getting behind the wheel.

Vesicare is a medication that can be affected by any over-the-counter medication or prescription medications that you are already taking. Before starting Vesicare be sure to discuss other medications or herbal supplements you are taking with both your physician and your pharmacist. This includes vitamins, minerals and and drugs prescribed by other doctors.

Very rarely an individual will be allergic to solifenacin which is one of the primary active ingredients in Vesicare. If you are allergic do not take this medication. The FDA has categorized this medication as category C for use during pregnancy. This means that it can be harmful to an unborn baby and if you\’re planning to become pregnant or are pregnant you should stop using this medication.

Vesicare can be taken with or without food, should be stored at room temperature and can be taken with just water. Overdose symptoms can include severe constipation, stomach pain and urinating either less than usual or not at all. Seek emergency medical attention if you believe you have taken too much medication.

Side effects to Vesicare include upper abdominal pain, vomiting, sore throat, dizziness, dry eyes, fatigue, swelling, costs and high blood pressure. Some individuals experienced non-while others experience all of the side effects. Unfortunately, there is no way for healthcare providers to accurately predict who will be able to use this medication without side effects and who will not. Therefore, if you develop any side effects at all it is important to consult with your physician who prescribed the medication to determine whether or not you should continue to take it.

Vesicare is a viable option for treatment for those individuals whose suffer from overactive bladder. If you have this condition talk to your doctor before believing that you are unable to enjoy a social life anymore.

RESOURCES

Drugs.com: Vesicare

US National Library of Medicine: http://www.ncbi.nlm.nih.gov/